HEALTH

Book on integrating herbal, nutrient, and drug therapy is now available

BY Michael Johnsen

HOHENWALD, Tenn. Health Resources Unlimited recently published Herb, Nutrient and Drug Interactions: Clinical Implications and Therapeutic Strategies, a resource for retail clinicians and pharmacists that accounts for the growing number of consumers who are supplementing with herbs, vitamins and minerals in conjunction with traditional prescription or non-prescription therapies.

The clinical resource presents detailed, evidence-based coverage of the most commonly encountered therapeutic agents in modern clinical practice and is designed to help the practitioner to safely and effectively integrate herbal, nutrient and drug therapy for patients.

Combining pharmaceuticals with herbs or nutrients may complement or interfere with a drug’s therapeutic action or may increase adverse effects. Furthermore, drug-induced depletion of essential nutrients can occur. Comprehensive clinical data, quick-reference features, and the insight and expertise of trusted authorities offer a deeper understanding of how herbal remedies and nutritional supplements interact with pharmaceuticals.

The resource, which includes 70 comprehensive monographs of herb-drug and nutrient-drug interactions, covers the most commonly used herbs and nutrients in health-related practice. Each herb and nutrient monograph features summary tables and concise, practical suggestions that provide quick and easy reference and complement the systematic review and in-depth analysis.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Study shows cold and flu impair driver awareness

BY Michael Johnsen

NEWPORT, England More than 125,000 crashes were caused last year by motorists with colds and flu, according to research released by Lloyds TSB Insurance on Saturday.

“Our research proves that getting behind the wheel when ill causes thousands of accidents every year,” stated Paula Llewellyn, Lloyds spokeswoman.

Driving with a virus such as cold or flu impairs driver awareness by as much as 11%, the insurer noted, which is the equivalent of downing a double whisky before getting behind the wheel.

According to the motor insurance provider, one in 10 road accidents in 2008 can be attributed to flu – equating to a cost of $244.4 million in claims.

Despite the risks, public awareness of the problem is low, with 12 million (38%) admitting that they have driven while suffering from cold or flu – and half of these drivers (46%) believing that the illness has no affect at all on their driving ability.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

FTC: Solvay Pharmaceuticals violated antitrust laws

BY Drug Store News Team

WASHINGTON The maker of a hormone-replacement drug gained a monopoly and violated antitrust laws by paying three generic drug makers to delay release of their own versions, the Federal Trade Commission alleges in a suit.

The FTC said Solvay Pharmaceuticals, the maker of the topical medication Androgel (testosterone gel), told Watson Pharmaceuticals, Paddock Laboratories and Par Pharmaceuticals to delay release of generic versions of the gel until 2010, in exchange for a share of profits from the branded version.

Such deals are called exclusion payment settlements and involve branded drug makers paying generic drug makers to delay release of generic drugs. Several members of the Senate and House introduced legislation last year to challenge the practice.

Legislation has also been introduced in the House this year to prohibit the selling of authorized generics during the customary six-month exclusivity period, whereby a large drug maker will sell its drug through a generic drug maker at a reduced price to compete with the generic version.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?